Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy
Acta Pharmaceutica Sinica B · 2024-02 · 14 (2) · 795-807
DOI: 10.1016/j.apsb.2023.09.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-02. Verfasst von Yongchun Pan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Recent innovations in nanomaterials inspire abundant novel tumor-targeting CRISPR-based gene therapies. However, the therapeutic efficiency of traditional targeted nanotherapeutic strategies is limited by that the biomarkers vary in a spatiotemporal-dependent manner with tumor progression. Here, we propose a self-amplifying logic-gated gene editing strategy for gene/H2O2-mediated/starvation multimodal cancer therapy. In this approach, a hypoxia-degradable covalent-organic framework (COF) is synthesized to coat a-ZIF-8 in which glucose oxidase (GOx) and CRISPR system are packaged. To intensify intracellular redox dyshomeostasis, DNAzymes which can cleave catalase mRNA are loaded as well. When the nanosystem gets into the tumor, the weakly acidic and hypoxic microenvironment degrades the ZIF-8@COF to activate GOx, which amplifies intracellular H+ and hypoxia, accelerating the nanocarrier degradation to guarantee available CRISPR plasmid and GOx release in target cells. These tandem reactions deplete glucose and oxygen, leading to logic-gated-triggered gene editing as well as synergistic gene/H2O2-mediated/starvation therapy. Overall, this approach highlights the biocomputing-based CRISPR delivery and underscores the great potential of precise cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
- College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, China.
- State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 211198, China.
- School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Förderung
- Natural Science Foundation of Jiangsu Province
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Jiangsu Provincial Key Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Pan, Y., Luan, X., Zeng, F., Wang, X., Qin, S., Lu, Q., He, G., Gao, Y., Sun, X., Han, X., He, B., & Song, Y. (2024). Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy. Acta Pharmaceutica Sinica B, 14(2), 795-807. https://doi.org/10.1016/j.apsb.2023.09.016
Vancouver
Pan Y, Luan X, Zeng F, Wang X, Qin S, Lu Q, et al. Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy. Acta Pharmaceutica Sinica B. 2024;14(2):795-807. doi:10.1016/j.apsb.2023.09.016
BibTeX
@article{Pan2024,
author = {Pan, Yongchun and Luan, Xiaowei and Zeng, Fei and Wang, Xuyuan and Qin, Shurong and Lu, Qianglan and He, Guanzhong and Gao, Yanfeng and Sun, Xiaolian and Han, Xin and He, Bangshun and Song, Yujun},
title = {Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2024},
volume = {14},
number = {2},
pages = {795--807},
doi = {10.1016/j.apsb.2023.09.016}
}
EUVIMED